FDA Approved: YONSA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's supplemental application for YONSA (abiraterone acetate), a prostate cancer therapy. The approval authorizes the marketing of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• YONSA (abiraterone acetate)

Snippet

SUPPL AP for YONSA (ABIRATERONE ACETATE)